ABBOTT INDIA
Back to Balance Sheet
|
ABBOTT INDIA Last 5 Year Total Non-Current Liabilities History
[Standalone]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Non-Current Liabilities | ₹136 Cr | ₹144 Cr | ₹184 Cr | ₹190 Cr | ₹210 Cr |
What is the latest Total Non-Current Liabilities ratio of ABBOTT INDIA ?
Year | Total Non-Current Liabilities |
---|---|
Mar2024 | ₹136 Cr |
Mar2023 | ₹144 Cr |
Mar2022 | ₹184 Cr |
Mar2021 | ₹190 Cr |
Mar2020 | ₹210 Cr |
How is Total Non-Current Liabilities of ABBOTT INDIA Trending?
Years | Total Non-Current Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹136 Cr | -5.55 | |
Mar2023 | ₹144 Cr | -21.80 | |
Mar2022 | ₹184 Cr | -2.87 | |
Mar2021 | ₹190 Cr | -9.53 | |
Mar2020 | ₹210 Cr | - |
Compare Total Non-Current Liabilities of peers of ABBOTT INDIA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
ABBOTT INDIA | ₹66,795.7 Cr | 0.1% | 2.3% | 15.2% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹395,254.0 Cr | -2.3% | -3.5% | 9.2% | Stock Analytics | |
DIVIS LABORATORIES | ₹172,374.0 Cr | -2.8% | 1.3% | 42.3% | Stock Analytics | |
CIPLA | ₹119,795.0 Cr | -0.3% | 3% | -2.6% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹110,698.0 Cr | -3.7% | 7.2% | 8.2% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹107,218.0 Cr | -1% | -0.5% | 13.2% | Stock Analytics |
ABBOTT INDIA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
ABBOTT INDIA | 0.1% |
2.3% |
15.2% |
SENSEX | -1.3% |
-0.8% |
6.3% |
You may also like the below Video Courses